Related references
Note: Only part of the references are listed.Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Garrett S. Gibbons et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Genetic analysis of neurodegenerative diseases in a pathology cohort
Cornelis Blauwendraat et al.
NEUROBIOLOGY OF AGING (2019)
G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
An Phu Tran Nguyen et al.
HUMAN MOLECULAR GENETICS (2018)
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies
Garrett S. Gibbons et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons
Jason Schapansky et al.
NEUROBIOLOGY OF DISEASE (2018)
Progression in the LRRK2-Asssociated Parkinson Disease Population
Rachel Saunders-Pullman et al.
JAMA NEUROLOGY (2018)
Study of LRRK2 Variation in Tauopathy: Progressive Supranuclear Palsy and Corticobasal Degeneration
Monica Sanchez-Contreras et al.
MOVEMENT DISORDERS (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Penetrance Estimate of LRRK2 p.G2019S Mutation in Individuals of Non-Ashkenazi Jewish Ancestry
Annie J. Lee et al.
MOVEMENT DISORDERS (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Alzheimer's disease CSF biomarkers: clinical indications and rational use
Ellis Niemantsverdriet et al.
ACTA NEUROLOGICA BELGICA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Abolishing the 1-year rule: How much evidence will be enough?
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
PART is part of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
Evaluating LRRK2 Genetic Variants with Unclear Pathogenicity
Fathima Shaffra Refai et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
Nadia Magdalinou et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Neuropathologic substrates of Parkinson disease dementia
David J. Irwin et al.
ANNALS OF NEUROLOGY (2012)
Neurobiology of cognitive impairment in Parkinson's disease
Kurt A. Jellinger
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
The neuropathology of genetic Parkinson's disease
Markos Poulopoulos et al.
MOVEMENT DISORDERS (2012)
Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism
C. Ruffmann et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
C. Marras et al.
NEUROLOGY (2011)
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Christian Wider et al.
NEURODEGENERATIVE DISEASES (2010)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Clinical and Pathological Characteristics of Patients with Leucine-Rich Repeat Kinase-2 Mutations
Jason P. Covy et al.
MOVEMENT DISORDERS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology
Yoshio Tsuboi et al.
PARKINSONISM & RELATED DISORDERS (2007)
LRRK2 and Parkinson's disease in Norway
M. Toft et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Cognitive decline correlates with neuropathological stage in Parkinson's disease
Heiko Braak et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Lrrk2 R1441 substitution and progressive supranuclear palsy
OA Ross et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Biochemical and pathological characterization of Lrrk2
BI Giasson et al.
ANNALS OF NEUROLOGY (2006)
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease
[Anonymous]
BRAIN (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Dopamine miracle: From brain homogenate to dopamine replacement
E Hornykiewicz
MOVEMENT DISORDERS (2002)
Share Paper
